Nature Outlook |

Brain cancer

Brain cancer is one of the most aggressive and difficult-to-treat malignancies. Moreover, in the almost 50 years since the start of the war on cancer, the prospects for people who develop brain cancer have improved much more slowly than those of individuals with other types of cancer. Despite a lack of progress in the clinic, research on this group of conditions is advancing steadily, and treatments with the potential to transform the field are on the horizon.

This Nature Outlook is editorially independent. It is produced with third party financial support. About this content.

Features and comment

More from Nature Research

  • Nature Reviews Drug Discovery | Review Article

    Research on the blood–brain barrier (BBB) has led to the concept of a complex, dynamic interface between the central nervous system (CNS) and periphery. Banks considers how this new understanding can combine with classical concepts to inform CNS drug delivery strategies and promote BBB integrity in various diseases.

    • William A. Banks
  • Nature Reviews Cancer | Perspective

    This Opinion argues for a new look at the role of ABC transporters in cancer multidrug resistance to push forward their clinical application as biomarkers and as targets in combination therapies in order to improve anticancer drug efficiency.

    • Robert W. Robey
    • , Kristen M. Pluchino
    • , Matthew D. Hall
    • , Antonio T. Fojo
    • , Susan E. Bates
    •  &  Michael M. Gottesman
  • Scientific Reports | Article | open

    • Erica M. Rutter
    • , Tracy L. Stepien
    • , Barrett J. Anderies
    • , Jonathan D. Plasencia
    • , Eric C. Woolf
    • , Adrienne C. Scheck
    • , Gregory H. Turner
    • , Qingwei Liu
    • , David Frakes
    • , Vikram Kodibagkar
    • , Yang Kuang
    • , Mark C. Preul
    •  &  Eric J. Kostelich
  • Nature | Article

    Here the authors present a human pluripotent stem cell-derived three-dimensional organoid culture system that is able to recapitulate several aspects of human brain development in addition to modelling the brain disorder microcephaly, which has been difficult to achieve using mouse models.

    • Madeline A. Lancaster
    • , Magdalena Renner
    • , Carol-Anne Martin
    • , Daniel Wenzel
    • , Louise S. Bicknell
    • , Matthew E. Hurles
    • , Tessa Homfray
    • , Josef M. Penninger
    • , Andrew P. Jackson
    •  &  Juergen A. Knoblich
  • Nature Reviews Clinical Oncology | Review Article

    Glioblastoma is a disease associated with a dismal patient prognosis, necessitating the development of novel therapies. Substantial research effort is being devoted to the development of immunotherapies for glioblastoma. Herein, the rationale and promise for this approach are discussed, together with the challenges and how they might be overcome.

    • Michael Lim
    • , Yuanxuan Xia
    • , Chetan Bettegowda
    •  &  Michael Weller